Clinical Trial Update: Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic and clinical study of Envarsus once daily with Everolimus in elderly kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Envarsus (tacrolimus)
• Everolimus (everolimus)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Kidney Transplantation | Phase 2 | Status: COMPLETED